{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:33:37Z","timestamp":1754145217334,"version":"3.41.2"},"reference-count":10,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaccas.2025.104050","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T18:08:30Z","timestamp":1752689310000},"page":"104050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary Arterial Hypertension After Busulfan Administration During Conditioning Regimen in Neuroblastoma"],"prefix":"10.1016","volume":"30","author":[{"given":"Rachele","family":"Adorisio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gessica","family":"Ingrasciotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fabozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Secinaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Tom\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Mastronuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"De Ioris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccas.2025.104050_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41571-022-00643-z","article-title":"Advancing therapy for neuroblastoma","volume":"19","author":"Qiu","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jaccas.2025.104050_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27421","article-title":"Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue","volume":"66","author":"Elzembely","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaccas.2025.104050_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00612-2019","article-title":"Pulmonary hypertension after bone marrow transplantation in children","volume":"54","author":"Levy","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaccas.2025.104050_bib4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/bmt.2016.84","article-title":"Toxicities of busulfan\/melphalan versus carboplatin\/etoposide\/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma","volume":"51","author":"Desai","year":"2016","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jaccas.2025.104050_bib5","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccas.2025.104050_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ajpath.2014.10.021","article-title":"Chemotherapy-induced pulmonary hypertension: role of alkylating agents","volume":"185","author":"Ranchoux","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaccas.2025.104050_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00228-011-1209-y","article-title":"Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis","volume":"68","author":"Reimer","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaccas.2025.104050_bib8","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1046\/j.1365-2141.2002.03748.x","article-title":"Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide","volume":"118","author":"Lee","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaccas.2025.104050_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2023.105663","article-title":"Busulfan-induced hepatic sinusoidal endothelial cell injury: modulatory role of pirfenidone for therapeutic purposes","volume":"92","author":"Ma","year":"2023","journal-title":"Toxicol Vitr"},{"key":"10.1016\/j.jaccas.2025.104050_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211030170","article-title":"Pulmonary hypertension associated with busulfan","volume":"11","author":"Hagenburg","year":"2021","journal-title":"Pulm Circ"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925008319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925008319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T18:09:02Z","timestamp":1752689342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084925008319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":10,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2666084925008319"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.104050","relation":{},"ISSN":["2666-0849"],"issn-type":[{"type":"print","value":"2666-0849"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Arterial Hypertension After Busulfan Administration During Conditioning Regimen in Neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.104050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"104050"}}